放射性淋巴细胞减少对头颈癌预后影响:系统评价与Meta分析
该系统评价与Meta分析纳入8项研究共2733例头颈癌患者,评估放射性淋巴细胞减少(RIL)的预后作用。发生3-4级RIL的比值比为13.49(95%CI=7.03-25.89,I2=94%),3-4级RIL发生率为73%-88%。多因素Meta分析显示RIL显著降低总生存(HR=2.94,95%CI=1.83-4.74,I2=0%)和无远处转移生存(HR=3.79,95%CI=2.06-6.97,I2=0%)。
要点
- 3-4级RIL发生率为73%-88%,发生3-4级RIL的比值比为13.49(95%CI=7.03-25.89,I2=94%)。
- RIL显著降低头颈癌总生存(HR=2.94,95%CI=1.83-4.74,I2=0%)。
- RIL显著降低无远处转移生存(HR=3.79,95%CI=2.06-6.97,I2=0%)。
核心结论
- 严重RIL降低头颈癌患者总生存并促进疾病进展。
- 未来需大规模前瞻性研究评估严重RIL与头颈癌预后的关联。
研究设计与样本
- 基于PRISMA指南的系统评价与Meta分析,检索PubMed、Embase和Cochrane Library从2007年至2021年10月的文献。
- 最终纳入8项研究共2733例样本。
- 采用纽卡斯尔-渥太华量表(NOS)评估每项研究质量。
主要发现
- 发生3-4级RIL的比值比为13.49(95%CI=7.03-25.89,I2=94%)。
- 3-4级RIL的发生率范围为73%-88%。
- 多因素Meta分析显示RIL显著降低总生存(HR=2.94,95%CI=1.83-4.74,I2=0%)和无远处转移生存(HR=3.79,95%CI=2.06-6.97,I2=0%)。
- 敏感性分析排除一项导致异质性的潜在研究后,新的汇总多因素Meta分析显示RIL是无进展生存的风险因素(HR=3.16,95%CI=1.77-5.63,I2=0%)。
关键数值与推荐
- 发生3-4级RIL的比值比为13.49(95%CI=7.03-25.89,I2=94%)。
- 3-4级RIL发生率为73%-88%。
- RIL降低总生存的HR为2.94(95%CI=1.83-4.74,I2=0%)。
- RIL降低无远处转移生存的HR为3.79(95%CI=2.06-6.97,I2=0%)。
- 敏感性分析后RIL对无进展生存的HR为3.16(95%CI=1.77-5.63,I2=0%)。
局限性
- 发生3-4级RIL的比值比合并分析异质性I2=94%。
- 未来需大规模前瞻性研究评估严重RIL与头颈癌预后的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Radiotherapy is a key part of head and neck cancer (HNC) treatment. Radiation induced lymphopenia (RIL) is a severe complication of radiotherapy. The aim of this study was to evaluate the prognostic role of RIL in HNC patients. METHOD: We conducted a PRISMA guideline based systematic review and meta-analysis. The studies were identified on the PubMed, Embase and Cochrane Library from 2007 to October 2021. The quality of each study was assessed by Newcastle-Ottawa Quality Assessment Form for Cohort Studies (NOS). RESULTS: There were 8 studies with 2,733 samples finally included in current study. The meta-analysis showed that the odds ratio of developing grade 3-4 RIL was 13.49 (95%CI = 7.03-25.89, I2 = 94%). The incidence rate of grade 3-4 RIL ranged from 73%-88%. Multivariate meta-analysis found that the RIL significantly decreased the overall survival (HR = 2.94, 95%CI = 1.83-4.74, I2 = 0%) and distant metastasis free survival of HNC (HR = 3.79, 95%CI = 2.06-6.97, I2 = 0%). After sensitivity analysis and excluding a potential study that caused heterogeneity, the new pooled multivariate meta-analysis showed RIL was a risk factor to the progression free survival of HNC patients (HR = 3.16, 95%CI = 1.77-5.63, I2 = 0%). CONCLUSION: This is the first meta-analysis which showed severe RIL decreased the overall survival and promoted the progression of HNC patients. Future large-scale prospective studies are required to evaluate the association between severe RIL and the prognosis of HNC.
引用
- Dai D, Tian Q, Shui Y, et al. The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: A systematic review and meta-analysis. Radiother Oncol. 2022. PMID: 35017020. doi:10.1016/j.radonc.2022.01.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。